← Leaderboards
David E Smith
University Of Michigan At Ann Arbor
$4,530,256
Attributed
$5,378,116
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $432.7K · FY2005–18$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$5,378,116 · 2
By mechanism
R01$5,378,116 · 2
Top collaborators
- Gordon L Amidon4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Malini Raghavan$15,429,161
- Gordon L Amidon$5,280,112
- Richard F Keep$6,288,652
- David J. Pinsky$32,329,328
- Thomas M Glaser$11,430,561
Others in their field
Top investigators on “Oligopeptides”
- Anthony G Letai · Dana-Farber Cancer Inst$7,030,366
- Jindrich N. Kopecek · Utah State Higher Education System--University Of Utah$4,750,568
- Ganes C. Sen · Cleveland Clinic Foundation$4,471,860
- Scott G. Franzblau · University Of Illinois At Chicago$4,081,438
- Edward David Crandall · University Of Southern California$3,683,202
- Douglas C Wallace · Emory University$3,330,838
Research focus
OligopeptidesMalignant NeoplasmsIn VivoTherapeutic AgentsPharmaceutical PreparationsMemberLaboratoriesTissuesProdrugsProteinsIntestinal AbsorptionPropertyPeptidesAnimalsNeuropeptidesKnockout MiceHuman SubjectInterestDoseDietHypertensionKidneyAngiotensin-Converting Enzyme InhibitorsAffect
Grant awards (19)
Novel Transport and Activation Strategy to Improve the Bioavailability of Targeted Prodrugs$423,930
R01 · FY2018 · GM · contact PI
Novel Transport and Activation Strategy to Improve the Bioavailability of Targeted Prodrugs$423,930
R01 · FY2017 · GM · contact PI
Novel Transport and Activation Strategy to Improve the Bioavailability of Targeted Prodrugs$423,930
R01 · FY2016 · GM · contact PI
Novel Transport and Activation Strategy to Improve the Bioavailability of Targeted Prodrugs$423,930
R01 · FY2015 · GM · contact PI
Role and Relevance of Pept1 in Drug Absorption, Disposition, and Dynamics$325,277
R01 · FY2013 · GM · contact PI
Role and Relevance of Pept1 in Drug Absorption, Disposition, and Dynamics$337,345
R01 · FY2012 · GM · contact PI
Role and Relevance of Pept1 in Drug Absorption, Disposition, and Dynamics$95,367
R01 · FY2012 · GM · contact PI
Role and Relevance of Pept1 in Drug Absorption, Disposition, and Dynamics$337,437
R01 · FY2011 · GM · contact PI
Role and Relevance of Pept1 in Drug Absorption, Disposition, and Dynamics$335,498
R01 · FY2010 · GM · contact PI
Role of PEPT2 in Peptide/Mimetic Disposition-Dynamics$290,959
R01 · FY2009 · GM · contact PI
Role of PEPT2 in Peptide/Mimetic Disposition-Dynamics$290,959
R01 · FY2008 · GM · contact PI
Role of PEPT2 in Peptide/Mimetic Disposition-Dynamics$290,959
R01 · FY2007 · GM · contact PI
Role of PEPT2 in Peptide/Mimetic Disposition-Dynamics$300,608
R01 · FY2006 · GM · contact PI
Peptide/Mimetic Transport Mechanisms in Choroid Plexus$56,289
R01 · FY2005 · GM
Peptide/Mimetic Transport Mechanisms in Choroid Plexus$248,578
R01 · FY2004 · GM
Peptide/Mimetic Transport Mechanisms in Choroid Plexus$248,578
R01 · FY2003 · GM
Peptide/Mimetic Transport Mechanisms in Choroid Plexus$248,578
R01 · FY2002 · GM
Peptide/Mimetic Transport Mechanisms in Choroid Plexus$27,180
R01 · FY2002 · GM
Peptide/Mimetic Transport Mechanisms in Choroid Plexus$248,784
R01 · FY2001 · GM